NewGenIvf (NIVF) Return on Capital Employed (2025)
NewGenIvf (NIVF) posted quarterly Return on Capital Employed of 0.0% for Q4 2025.
NewGenIvf (NIVF) Return on Capital Employed (2025) Analysis & Trends
NewGenIvf has disclosed Return on Capital Employed across 1 years of filings, most recently posting 0.0% for Q4 2025.
- In Q4 2025, Return on Capital Employed changed N/A year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 67.96%, up 2049.0% from the prior year.
- Return on Capital Employed steadied at 0.0% in Q4 2025.
- Over the last five years, Return on Capital Employed for NIVF reached as high as 0.0% in Q4 2025 and fell as low as 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | -18.08% |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | 26.99% |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 15.90% |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 14.27% |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | -2.33% |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 9.57% |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 16.52% |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 8.38% |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | -0.28% |
| 10 | NewGenIvf | 25,304.95 | -1.41 Mn | 524,025.00 | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |